Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Jaguar Health, Inc.

< Previous 1 2 3 Next >
Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers JAGX
Jaguar Health to Participate in BIO International Convention (BIO 2022)
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications
From Jaguar Health, Inc.
Via AccessWire
Topics Economy
Tickers JAGX
Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd!
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd!
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Announces Launch of Mytesi Telehealth Program
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Provides Company Updates and Reports 2022 First Quarter Financials
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
UPDATED RELEASE: Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Animal Health Announces Commercial Availability of Plant-based Canalevia-CA1 (Crofelemer) Prescription Drug for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health to Present at the NobleCon18 Investor Conference on April 21, 2022
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4)
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Animal Health to Host Dinner & Tableside Discussion for U.S. Veterinary Oncologists About Chemotherapy-Induced Diarrhea (CID) in Dogs on April 12th, the Final Day of the Veterinary Cancer Society (VCS) Mid-Year Conference in Puerto Vallarta, Mexico
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Announces Appointment of Pravin Chaturvedi, Ph.D., as Chief Scientific Officer
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Enters Exclusive Crofelemer Distribution and License Agreement with Quadri Pharmaceuticals Store for Multiple Target Indications in Middle East Markets
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Shares Replay Link for March 14, 2022, Investor Webcast
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health Provides Company Updates and Reports 2021 Financials
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
Jaguar Health to Host Investor Webcast Monday, March 14th at 8:30 AM Eastern Time Regarding Q4 2021 Financials & Corporate Updates
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.